158 related articles for article (PubMed ID: 12372342)
1. Induction of DNA ligase I by 1-beta-D-arabinosylcytosine and aphidicolin in MiaPaCa human pancreatic cancer cells.
Sun D; Urrabaz R; Buzello C; Nguyen M
Exp Cell Res; 2002 Oct; 280(1):90-6. PubMed ID: 12372342
[TBL] [Abstract][Full Text] [Related]
2. Effects of cisplatin on expression of DNA ligases in MiaPaCa human pancreatic cancer cells.
Sun D; Urrabaz R; Buzello C; Nguyen M
Biochem Biophys Res Commun; 2002 Nov; 298(4):537-44. PubMed ID: 12408985
[TBL] [Abstract][Full Text] [Related]
3. Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML.
Sargent JM; Elgie AW; Williamson CJ; Lewandowicz GM; Taylor CG
Br J Cancer; 2001 Mar; 84(5):680-5. PubMed ID: 11237390
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of DNA ligase I level by gemcitabine in human cancer cells.
Sun D; Urrabaz R; Kelly S; Nguyen M; Weitman S
Clin Cancer Res; 2002 Apr; 8(4):1189-95. PubMed ID: 11948132
[TBL] [Abstract][Full Text] [Related]
5. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
Fram RJ; Kufe DW
Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
[TBL] [Abstract][Full Text] [Related]
6. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine.
Mirzayans R; Enns L; Cubitt S; Karimian K; Radatus B; Paterson MC
Biochim Biophys Acta; 1994 Oct; 1227(1-2):92-100. PubMed ID: 7918688
[TBL] [Abstract][Full Text] [Related]
7. Cellular response and molecular mechanism of antitumor activity by leinamycin in MiaPaCa human pancreatic cancer cells.
Bassett S; Urrabaz R; Sun D
Anticancer Drugs; 2004 Aug; 15(7):689-96. PubMed ID: 15269600
[TBL] [Abstract][Full Text] [Related]
8. Aphidicolin decreases ex vivo resistance to cytosine arabinoside in childhood acute leukaemia.
Sargent JM; Williamson CJ; Hubeek I; Elgie AW; Taylor CG; Den Boer ML; Peters GJ; Kaspers GL
Oncol Rep; 2003; 10(6):2027-31. PubMed ID: 14534738
[TBL] [Abstract][Full Text] [Related]
9. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
Abdel-Aziz W; Jiang HY; Hickey RJ; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):312-9. PubMed ID: 10755320
[TBL] [Abstract][Full Text] [Related]
10. Aphidicolin markedly increases the in vitro sensitivity to ara-C of blast cells from patients with AML.
Sargent JM; Elgie AW; Williamson CJ; Taylor CG
Adv Exp Med Biol; 1999; 457():567-70. PubMed ID: 10500835
[TBL] [Abstract][Full Text] [Related]
11. Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis.
Kuwakado K; Kubota M; Bessho R; Kataoka A; Usami I; Lin YW; Okuda A; Wakazono Y
Leuk Res; 1995 Sep; 19(9):645-50. PubMed ID: 7564475
[TBL] [Abstract][Full Text] [Related]
12. Etoposide induces the dispersal of DNA ligase I from replication factories.
Montecucco A; Rossi R; Ferrari G; Scovassi AI; Prosperi E; Biamonti G
Mol Biol Cell; 2001 Jul; 12(7):2109-18. PubMed ID: 11452007
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of X-ray toxicity in squamous cell carcinoma cell lines by DNA polymerase inhibitors.
Mustafi R; Heaton D; Brinkman W; Schwartz JL
Int J Radiat Biol; 1994 Jun; 65(6):675-81. PubMed ID: 7912717
[TBL] [Abstract][Full Text] [Related]
14. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
Catapano CV; Chandler KB; Fernandes DJ
Cancer Res; 1991 Apr; 51(7):1829-35. PubMed ID: 1706219
[TBL] [Abstract][Full Text] [Related]
16. The mode of action of 1-beta-D-arabinofuranosylcytosine in inhibiting DNA repair; new evidence using a sensitive assay for repair DNA synthesis and ligation in permeable cells.
Gedik CM; Collins AR
Mutat Res; 1991 May; 254(3):231-7. PubMed ID: 1904985
[TBL] [Abstract][Full Text] [Related]
17. Chinese hamster ovary cell mutants resistant to DNA polymerase inhibitors. I. Isolation and biochemical genetic characterization.
Vishwanatha JK; Mishra NC
Mol Gen Genet; 1985; 200(3):393-400. PubMed ID: 3930921
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
19. Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin.
Wu J; Yin MB; Hapke G; Tóth K; Rustum YM
Mol Pharmacol; 2002 Apr; 61(4):742-8. PubMed ID: 11901212
[TBL] [Abstract][Full Text] [Related]
20. Control of cell division by aphidicolin without adverse effects upon resting cells.
Spadari S; Focher F; Sala F; Ciarrocchi G; Koch G; Falaschi A; Pedrali-Noy G
Arzneimittelforschung; 1985; 35(7):1108-16. PubMed ID: 3931652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
